Prostate cancer
Results
Pilot
This trial looked at a short course of apalutamide for early stage prostate cancer. It was for men whose cancer was contained within the prostate gland but there was a risk it may grow. They were being monitored (active surveillance).
The trial was open for people to join between 2018 and 2019. The researchers published the results in 2022.
Recruitment start: 5 June 2018
Recruitment end: 10 May 2019
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Vincent J Gnanapragasam
Cambridge University Hospitals NHS Foundation Trust
Cambridge Clinical Trials Unit
Janssen-Cilag
University of Cambridge
Last reviewed: 9 November 2023
CRUK internal database number: 15423